The recent discussions around marijuana regulation have stirred quite a bit of attention. Sara Carter Bailey, the director of the White House Office of National Drug Control Policy, recently clarified that even with the potential federal rescheduling of marijuana, it doesn’t mean cannabis is fully legal.
In an interview with Newsmax, she reiterated, “It’s still illegal.” The rescheduling to Schedule III mostly opens the door for research and medical use, not for general consumption.
Her comments came during a discussion on the new National Drug Control Strategy, which raises concerns about “high-potency” marijuana. The strategy warns that international crime groups exploit state laws on cannabis. According to a report by the Congressional Research Service, this move provides some protections for patients using medical cannabis from licensed dispensaries, but it doesn’t mean the whole industry complies with federal law just yet.
Carter highlighted alarming trends of illicit marijuana farms linked to international cartels and even the Chinese Communist Party. She also pointed out an increase in product potency, with some reaching as high as 90%. “Our law enforcement is actively targeting these growths,” she said. The concern is not just for public safety but also for agricultural integrity, as she emphasized the importance of protecting American farmland.
Interestingly, Carter had expressed support for medical cannabis prior to her current role. She believes that when monitored, cannabis could be beneficial for patients dealing with cancer and other serious illnesses. In her words, “Cannabis for medicinal purposes is a fantastic way of handling the illness and the side effects.”
This balancing act of regulation, medicine, and public safety reflects a broader societal conversation about marijuana. As legality evolves, so do public perceptions, with many advocating for both the medical benefits and the need for strict oversight.
For further reading on the issue and its implications, you can refer to details provided by the Congressional Research Service here.
Staying informed about these developments will help shape the ongoing discussion about cannabis’s role in healthcare and law.
Source link
featured
